No Data
ct enterprise (03839.HK) will hold a board of directors meeting on November 12 to approve performance.
ct enterprise (03839.HK) announced on October 30 that the board of directors will hold a board meeting on November 12, 2024, to approve the unaudited performance of the company and its subsidiaries for the nine months ended September 30, 2024, as part of it.
Express News | National Medical Products Administration: Deploys pilot work on segmented production reform of biological products.
Who's buying? The A-share market is closed, but the Hong Kong stock market is still going strong! There's a big shift in foreign capital underway.
According to the latest report published by Goldman Sachs, after the People's Bank of China announced easing measures and the September Political Bureau meeting, mainland consumer stocks rebounded strongly by an average of about 32% in the past week.
Express News | Hong Kong stock CRO concept stocks soared at the close, what happened?
CT ENTERPRISE: Interim Report 2024
Performance: China Grand Pharmaceutical and Healthcare Holdings Limited (03839.HK) reported a net profit of 1.96 million US dollars in the first half of the year, a decrease of 3%, and no dividend payout.
CT Enterprise (03839.HK) announced its performance for the six months ended in June. Revenue increased 30.4% year-on-year to 0.108 billion USD. Net profit was 1.96 million USD, a decline of 3.2%, and earnings per share were 0.8 US cents. No interim dividend will be distributed.
No Data
No Data